This has led to the development of cancer-related biomarkers as well as new targeted therapies including proliferation markers such as Ki-67, p53, and PTEN; the hypoxia-inducible factor pathway; carbonic anhydrase IX; and vascular endothelial growth factor (VEGF) [52]. Here, TP53 is linked to cancer.